PAPER Trippier PC, Zhao KT, Fox SG, Schiefer IT, Benmohamed R, Moran J, Kirsch DR, Morimoto RI, Silverman RB
SEARCH RESULTS
229120 RESULTS
PAPER Tzen KY, Yang SY, Chen TF, Cheng TW, Horng HE, Wen HP, Huang YY, Shiue CY, Chiu MJ
Plasma Aβ but not tau is related to brain PiB retention in early Alzheimer's disease.
ACS Chem Neurosci. 2014 Sep 17;5(9):830-6. Epub 2014 Aug 13 PubMed.PAPER Bubser M, Bridges TM, Dencker D, Gould RW, Grannan M, Noetzel MJ, Lamsal A, Niswender CM, Daniels JS, Poslusney MS, Melancon BJ, Tarr JC, Byers FW, Wess J, Duggan ME, Dunlop J, Wood MW, Brandon NJ, Wood MR, Lindsley CW, Conn PJ, Jones CK
Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents.
ACS Chem Neurosci. 2014 Oct 15;5(10):920-42. Epub 2014 Aug 19 PubMed.PAPER Qiu L, Zhang W, Tan EK, Zeng L
Deciphering the function and regulation of microRNAs in Alzheimer's disease and Parkinson's disease.
ACS Chem Neurosci. 2014 Oct 15;5(10):884-94. Epub 2014 Sep 25 PubMed.PAPER Wang Q, Liang G, Zhang M, Zhao J, Patel K, Yu X, Zhao C, Ding B, Zhang G, Zhou F, Zheng J
De novo design of self-assembled hexapeptides as β-amyloid (Aβ) peptide inhibitors.
ACS Chem Neurosci. 2014 Oct 15;5(10):972-81. Epub 2014 Aug 22 PubMed.PAPER Wang Z, Wang Y, Li W, Mao F, Sun Y, Huang L, Li X
Design, synthesis, and evaluation of multitarget-directed selenium-containing clioquinol derivatives for the treatment of Alzheimer's disease.
ACS Chem Neurosci. 2014 Oct 15;5(10):952-62. Epub 2014 Aug 22 PubMed.PAPER Cárdenas-Aguayo Md, Gómez-Virgilio L, DeRosa S, Meraz-Ríos MA
The role of tau oligomers in the onset of Alzheimer's disease neuropathology.
ACS Chem Neurosci. 2014 Dec 17;5(12):1178-91. Epub 2014 Oct 15 PubMed.PAPER Kabiraj P, Marin JE, Varela-Ramirez A, Zubia E, Narayan M
Ellagic acid mitigates SNO-PDI induced aggregation of Parkinsonian biomarkers.
ACS Chem Neurosci. 2014 Dec 17;5(12):1209-20. Epub 2014 Oct 8 PubMed.PAPER Kosten J, Binolfi A, Stuiver M, Verzini S, Theillet FX, Bekei B, van Rossum M, Selenko P
Efficient modification of alpha-synuclein serine 129 by protein kinase CK1 requires phosphorylation of tyrosine 125 as a priming event.
ACS Chem Neurosci. 2014 Dec 17;5(12):1203-8. Epub 2014 Oct 22 PubMed.PAPER Mariano M, Schmitt C, Miralinaghi P, Catto M, Hartmann RW, Carotti A, Engel M
First selective dual inhibitors of tau phosphorylation and Beta-amyloid aggregation, two major pathogenic mechanisms in Alzheimer's disease.
ACS Chem Neurosci. 2014 Dec 17;5(12):1198-202. Epub 2014 Sep 26 PubMed.PAPER Sebollela A, Mustata GM, Luo K, Velasco PT, Viola KL, Cline EN, Shekhawat GS, Wilcox KC, Dravid VP, Klein WL
Elucidating molecular mass and shape of a neurotoxic Aβ oligomer.
ACS Chem Neurosci. 2014 Dec 17;5(12):1238-45. Epub 2014 Nov 7 PubMed.PAPER Kozai TD
Brain Tissue Responses to Neural Implants Impact Signal Sensitivity and Intervention Strategies.
ACS Chem Neurosci. 2014 Dec 29; PubMed.PAPER Basak S, Prasad GV, Varkey J, Chattopadhyay K
Early sodium dodecyl sulfate induced collapse of α-synuclein correlates with its amyloid formation.
ACS Chem Neurosci. 2015 Feb 18;6(2):239-46. Epub 2014 Nov 17 PubMed.PAPER Buendia I, Egea J, Parada E, Navarro E, León R, Rodríguez-Franco MI, López MG
The melatonin-N,N-dibenzyl(N-methyl)amine hybrid ITH91/IQM157 affords neuroprotection in an in vitro Alzheimer's model via hemo-oxygenase-1 induction.
ACS Chem Neurosci. 2015 Feb 18;6(2):288-96. Epub 2014 Nov 25 PubMed.PAPER Kakish J, Tavassoly O, Lee JS
Rasagiline, a suicide inhibitor of monoamine oxidases, binds reversibly to α-synuclein.
ACS Chem Neurosci. 2015 Feb 18;6(2):347-55. Epub 2014 Dec 16 PubMed.Current Filters
- TYPE: Paper x